Senate Bill 68 aims to amend the prescription drug monitoring program (PDMP) in Wisconsin by extending certain requirements related to the review of patient records and the evaluation of the program's outcomes. Specifically, the bill extends the requirement for practitioners to review a patient's records before issuing a prescription from its original expiration date of April 1, 2025, to April 1, 2030. Additionally, it extends the mandate for the Controlled Substances Board to conduct a quarterly review of the PDMP from October 30, 2025, to October 30, 2030.

The proposed changes are intended to enhance the oversight and effectiveness of the PDMP, ensuring that practitioners continue to assess patient records before prescribing monitored drugs and that the board evaluates the program's performance over a longer period. These amendments reflect a commitment to addressing substance abuse and improving patient safety in the state.

Statutes affected:
Bill Text: 961.385(2)(cs)1, 961.385, 961.385(5)(b), 961.385(6)(a)
Text as Enrolled: 961.385(2)(cs)1, 961.385, 961.385(5)(b), 961.385(6)(a)